middle.news
Proteomics International Secures Australian Patent for PromarkerEndo Diagnostic
8:46am on Thursday 13th of August, 2026 AEST
•
Healthcare
Read Story
Proteomics International Secures Australian Patent for PromarkerEndo Diagnostic
8:46am on Thursday 13th of August, 2026 AEST
Key Points
Australian patent accepted for PromarkerEndo diagnostic test
Patent protection expected until March 2041
Test offers accurate, non-invasive diagnosis of endometriosis
Patent complements granted protections in US and Japan
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Proteomics International Laboratories (ASX:PIQ)
OPEN ARTICLE